Company: MLSS
Filing Date: 2025-08-14
Form Type: 10-Q
Source: 0001437749-25-026919
Chunk: 10

Company: MILESTONE SCIENTIFIC INC.
Filing Date: 2025-08-14
Form: 10-Q
Item: Part I, Item 1
Chunk 10
---
,792and527,625, respectively, shares to be issued to non-employees, that will be issued to non-employees for services rendered. The number of shares was fixed by contract prior to the date of grant, subject to performance, and were fully earned upon the grant date.

The following table summarizes information about shares to be issued for the sixmonth periods endingJune 30, 2025and2024.

                                                                               June 30, 2025                     June 30, 2024                 
  Shares-to-be-issued, outstanding January 1, 2025 and 2024, respectively                         3,393,017                         3,098,917  
 ───────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
  Granted in current period                                                                         315,646                           438,868  
  Issued in current period                                                                                -                         ( 353,102  
  Shares-to be issued outstanding June 30, 2025 and 2024, respectively                            3,708,663                         3,184,683  

NOTE 8 - STOCK OPTION PLANS

Milestone Scientific Inc., the Amended and Restated2020Equity Incentive Plan, provides for awards of restricted common, stock restricted stock units, options to purchase and other awards. On June28,2023the plan was amended and restated (the"2020Plan") to increase the maximum shares that can be issued thereunder to11,500,000shares of common stock. The plan expires in June 2031. Options maybe granted to employees, directors, and consultants of Milestone Scientific for the purchase of shares of common stock at a price notless than the fair market value of common stock on the date of grant. Generally, options become exercisable over a three-year period from the grant date and expire fiveyears after the date of grant.

Milestone Scientific recognizes compensation expenses over the requisite service period and in the case of performance-based options over the period of the expected performance. For the threeand sixmonths endedJune 30, 2025, Milestone Scientific recognized approximately $158,000and$329,000 oftotal employee compensation cost, respectively, recorded in general and administrative expenses on the statement of operations. For the threeand sixmonths endedJune 30, 2024, Milestone Scientific recognized approximately $170,000and$358,000 oftotal employee compensation cost, respectively, recorded in general and administrative